December 17, 2018

Teneobio and Selexis Enter Second Services Agreement to Develop Research Cell Banks as Teneobio Prepares to Advance Three Additional Oncology-Targeting Multi-Specific UniAbs into the Clinic

Read More
December 03, 2018

KBI Biopharma Inc. and Selexis SA Form Joint Scientific Advisory Board

Read More
October 18, 2018

Selexis and Berkeley Lights Collaborate to Accelerate Cell Line Development with the Beacon Optofluidic Platform

Read More

Media Downloads